A phase I/II study of weekly nab-Paclitaxel/Cisplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer
Phase of Trial: Phase I/II
Latest Information Update: 19 Mar 2018
Price : $35 *
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Mar 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan